Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds IsoPlexis Granted U.S. Patent Titled ‘METHODS OF USING NUCLEOTIDE ANALOGUES’

Legal
News

IsoPlexis Granted U.S. Patent Titled ‘METHODS OF USING NUCLEOTIDE ANALOGUES’

https://ppubs.uspto.gov/pubwebapp/

byBenzinga Newsdesk

January 10, 2023

1 minute read

https://ppubs.uspto.gov/pubwebapp/

Cogent Comms Hldgs Q2 EPS $0.41 Beats $0.25 Estimate

By Benzinga Newsdesk

August 4, 4:47 PM

Cogent Comms Hldgs (NASDAQ:CCOI) reported quarterly earnings of $0.41 per share which beat the analyst consensus estimate of $0.25 by 64 percent. This is a 105 percent increase over earnings of $0.20 per share from the

CCOI

Porsche With No Brakes – Shares Race Higher In Landmark Frankfurt IPO

By Shivani Kumaresan

September 29, 6:24 AM

Shares of Volkswagen AG (OTC: VWAGY) owned sports car maker Porsche rose in its Frankfurt stock market debut.

VWAGY

Grab Reiterates FY23 Revenue Outlook $2.20B – $2.30B Vs. $2.21B Estimate

By Benzinga Newsdesk

May 18, 7:08 AM

Business Outlook Financial Measure Guidance FY 2023 Revenue $2.20 billion - $2.30 billion, 54% - 60%

GRAB

Enbridge Posts Higher Q2 EPS, Reaffirms 2023 And Medium-Term Guidance

By Lekha Gupta

August 4, 10:38 AM

Enbridge Inc (NYSE: ENB) reported second-quarter (Q2) 2023 adjusted EPS of C$0.68,

ENB

IsoPlexis Granted U.S. Patent Titled ‘METHODS OF USING NUCLEOTIDE ANALOGUES’

Related Posts

Cogent Comms Hldgs Q2 EPS $0.41 Beats $0.25 Estimate

Porsche With No Brakes – Shares Race Higher In Landmark Frankfurt IPO

Grab Reiterates FY23 Revenue Outlook $2.20B – $2.30B Vs. $2.21B Estimate

Enbridge Posts Higher Q2 EPS, Reaffirms 2023 And Medium-Term Guidance